CKAP4 and cancer: CKAP4-targeted aptamers present dual-action blocking of CKAP’s interaction with DKK1 and, thus, disrupting PIK/Akt signaling as well as impeding cancer cell adhesion and migration by decreasing internalization and recycling of α5β1 integrin [46].